GD

Ramsay Generale de Sante SAPAR Ramsay Generale Stock Report

Last reporting period 31 Dec, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

1.818

Small

Exchange

XPAR - Euronext Paris

GDS.PA Stock Analysis

GD

Uncovered

Ramsay Generale de Sante SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

7/100

Low score

Market cap $B

1.818

Dividend yield

15.52 %

Shares outstanding

110.37 B

Ramsay Générale de Santé SA engages in the provision of health care services. The company is headquartered in Paris, Ile-De-France and currently employs 33,231 full-time employees. The company went IPO on 2001-06-19. The firm offers a range of hospital services and, in partnership with independent medical specialists, delivers a spectrum of care services, including oncology and radiation therapy; care for alcohol abuse and obesity; rehabilitation, such as cardiac rehabilitation and orthopedic and neurological reeducation, and diagnostics, such as medical imaging and analysis. In addition, the Company develops a care package, offering care with personal support, before, during and after hospitalization. The firm operates approximately 75 centers and institutions in France. The firm operates through a number of subsidiaries, such as HPM Hopital Prive Metropole SAS. Ramsay Health Care (UK) Ltd is the major shareholder of the Company.

View Section: Eyestock Rating